The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons

H. Falconer1,2, C.S. Bambra2, D. Chai2, F.J. Cornillie3, J.A. Hill4 and T.M. D’Hooghe2,5,6

1 Department of Obstetrics and Gynaecology, Karolinska Hospital, Stockholm, Sweden, 2 Institute of Primate Research, Nairobi, Kenya, 3 Centocor B.V. Heverlee, Belgium, 4 New England Fertility Center, Reading, Massaschusetts, USA and 5 Leuven University Fertility Center, Department of Obstetrics and Gynecology, UZ Gasthuisberg, KU Leuven, Leuven, Belgium

6 To whom correspondence should be addressed at: Leuven University Fertility Center, UZ Gasthuisberg, Herestraat 49, B-3000. Leuven, Belgium. E-mail: Thomas.dhooghe{at}uz.kuleuven.ac.be


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
BACKGROUND: Serum CA-125 during the mid-follicular phase has been reported to be a clinically useful and reproducible marker in the diagnosis of advanced endometriosis in women. This study was undertaken to document the effect of the menstrual cycle, pregnancy and lymphocyte suppression on CA-125 levels in peritoneal fluid (PF) and serum in baboons with a normal pelvis and baboons with endometriosis. METHODS: CA-125 levels were measured in 264 serum samples that were serially obtained during one menstrual cycle from 10 animals with and without endometriosis. In addition, CA-125 levels were determined in 204 archived samples (serum, n = 112 and PF, n = 92) obtained from 32 female baboons with or without endometriosis. The CA-125 assays were performed by radioimmunoassay using kits from Centocor (Malvern, PA, USA). RESULTS: Serum CA-125 levels were at their highest during menstruation and decreased progressively during the follicular and luteal phase. PF CA-125 levels were increased during the follicular phase in baboons with a normal pelvis, but no cyclic changes were observed in animals with endometriosis. Serum CA-125 levels were unaffected by induction, lymphocyte suppression or pregnancy. Induction of endometriosis resulted in increased PF CA-125 levels, whereas lymphocyte suppression or pregnancy had no effect. CONCLUSION: In baboons, serum CA-125 originates mainly from eutopic endometrium whereas the main source of PF CA-125 seems to be the peritoneum or ectopic endometrium. The baboon appears to be a valid model to further study the relationship between endometriosis and CA-125.

Key words: baboon/CA-125/endometriosis


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
CA-125 is a cell surface antigen which is expressed in tissues derived from embryonic coelomic epithelium such as endometrium, endocervix, Fallopian tubes, peritoneum, pleura and pericardium (Kabawat et al., 1983Go). It is present in low concentrations in serum from healthy women. Elevated concentrations are found in women with epithelial ovarian carcinoma (Bast et al., 1983Go). Various studies have demonstrated elevated serum CA-125 concentrations in serum of patients with endometriosis (Barbieri et al., 1986Go; Patton et al., 1986Go; Pittaway and Fayez, 1986Go; Pittaway and Douglas, 1989Go). Similarly, increased serum CA-125 concentrations have been reported in rhesus monkeys with spontaneous endometriosis (Pittaway et al., 1986Go). The use of serial CA-125 concentrations in serum has been recommended to monitor endometriosis in infertile women (Pittaway, 1990Go). A valid method to measure CA-125 concentrations in peritoneal fluid (PF) has been reported by Kruitwagen et al. (1991aGo,bGo). These studies showed that the mean PF CA-125 concentration and total amount were significantly lower during the luteal phase when compared with other phases of the menstrual cycle. No correlation was found with the presence or absence of endometriosis and adhesions.

Due to ethical restrictions for performing serial laparoscopies in women, it is difficult to correlate the spontaneous evolution of endometriosis with serum and PF CA-125 concentrations. Such studies can only be done in non-human primates with spontaneous endometriosis. Additionally, the effect of lymphocyte suppression and of induction of endometriosis on CA-125 levels can be studied in this animal model. A high prevalence of spontaneous endometriosis (25%) has been reported in baboons of proven fertility (D’Hooghe et al., 1991Go) and the disease seems to be progressive (D’Hooghe et al., 1992Go, 1996aGo). The current study was undertaken to document the concentration of CA-125 in serum and PF during the menstrual cycle in baboons with endometriosis and controls, and to assess the effect of the induction of endometriosis (intrapelvic injection of menstrual endometrium) (D’Hooghe et al., 1995aGo), lymphocyte suppression (D’Hooghe et al., 1995bGo) and pregnancy (D’Hooghe and Debrock, 2002Go) on serum and PF CA-125 values. The following hypotheses were tested: (i) PF and serum CA-125 levels are increased in baboons during the menstrual phase when compared to the other phases of the cycle, as is known in women; (ii) serum and PF CA-125 levels are increased after induction of endometriosis due to CA-125 production originating from ectopic endometrium and/or other peritoneal tissues (D’Hooghe et al.,1995aGo,2001); (iii) lymphocyte suppression increases serum and PF CA-125 levels in baboons with endometriosis, since the progression of spontaneous endometriosis appears to be faster in immunosuppressed baboons than in controls (D’Hooghe et al.,1995bGo); (iv) pregnancy reduces serum and PF CA-125 levels in baboons with or without endometriosis, since it is generally believed that pregnancy reduces the extent and activity of endometriotic lesions (D’Hooghe and Debrock,2002Go).


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Study design
Part 1
This was a longitudinal study evaluating changes in serum CA-125 during the menstrual cycle in baboons with and without endometriosis. Serial serum samples were collected throughout the menstrual cycle from 10 baboons with a normal pelvis (n = 6) or with endometriosis (n = 4) (Table Ia). Samples were collected daily during the first 10 days and subsequently every second day from day 11 until the first day of the next menstruation.


View this table:
[in this window]
[in a new window]
 
Table Ia. Description of the number of animals and samples for part 1 of the study

 

Part 2
This was a cross-sectional study of CA-125 in serum and PF samples obtained during different stages of the menstrual cycle, to evaluate the impact of the induction of endometriosis, lymphocyte suppression and pregnancy. These samples were collected from a total of 32 baboons during previously published studies (D’Hooghe et al., 1991Go, 1992Go, 1995aGo, 1996aGo,bGo). This part of the study was subdivided into five parts (Table Ib): (i) determination of serum CA-125 values during different stages of the menstrual cycle; (ii) measurement of CA-125 values in PF during the menstrual cycle; (iii) studying the impact of induction of endometriosis on CA-125 in serum and PF; (iv) studying the impact of lymphocyte suppression by methylprednisolone and azathioprine on CA-125 in serum and PF; (v) studying the impact of pregnancy on CA-125 in serum and PF.


View this table:
[in this window]
[in a new window]
 
Table Ib. Description of the number of animals and samples for part 2 of the study

 

Baboons
The animals were all trapped in the wild and had been in captivity at the Institute of Primate Research between 9 and 47 months. The study protocol was reviewed and accepted by ISREC (Institutional and Scientific Ethical Committee). The animals were kept in single cages for ≥3 months prior to onset of the studies. Furthermore, all animals went through a diagnostic laparoscopy to screen the pelvic area for the presence of endometriosis or other abnormalities.

Monitoring of the menstrual cycle
The menstrual cycle was monitored through daily observations of the perineal skin (sex skin) (D’Hooghe et al., 1991Go; Bambra, 1993Go). No hormonal assays were performed in this study. The menstrual cycle in the baboon is divided into eight different stages, with stage 7 being menstrual phase, stage 1–5 follicular phase and 6, 0 luteal phase. The sex skin is monitored every day by trained animal technicians. The progressive inflation of the perineum throughout the cycle correlates with the follicular growth and the subsequent deflation (stage 6 and 0) to the luteal phase. Ovulation occurs during stage 5. An additional stage, stage 8, is similar to stage 0 (however more reddish) and becomes apparent during pregnancy (Hendrickx, 1971Go). The animals inflated and deflated normally during the studies and their cycle length was comparable to the cycle length they had established in the colony since captivity.

Sample collection
In the longitudinal part of the study, 264 peripheral blood (PB) samples were collected from the right or left forearm vein of the baboon. The PB was immediately centrifuged and sera were snap-frozen in liquid nitrogen and stored at –80°C before being analysed.

In the cross-sectional part of the study, a total of 112 PF and 92 serum samples were analysed. These samples had all been obtained and archived from other studies performed at IPR. Serum samples were handled as described above. The PF was aspirated during laparoscopy before the animal was placed in the Trendelenburg position and stored at –80°C before being analysed, as described previously (D’Hooghe et al.,1991Go).

Both serum and PF samples were freeze-thawed only once during the studies. During the study period of 2 years, five animals with an initially normal pelvis developed endometriosis at a later stage and were therefore used both as controls and as primates with spontaneous endometriosis.

Laparoscopies and induction of endometriosis
Laparoscopies and anaesthesia were carried out as previously described (D’Hooghe et al., 1991Go). The pelvic area was thoroughly screened for the presence of endometriosis. Spontaneous endometriosis was classified according to the rAFS (ASRM) classification system (D’Hooghe et al.,1991Go). Lesions were characterized either as typical blue-black, red or white. Endometriosis was induced as previously described (D’Hooghe et al., 1995aGo). Briefly, endometrium obtained through transcervical curettage was seeded onto the pelvic area under laparoscopic vision.

Lymphocyte suppression
A daily injection of 0.8 mg/kg i.m. methylprednisolone and 2 mg/kg azathioprine was performed for 3 months in 11 baboons (three animals with induced endometriosis, five baboons with spontaneous endometriosis and three controls with a normal pelvis, Table I), as described previously (D’Hooghe et al., 1995bGo).

Pregnancy
Serum and peritoneal fluid samples were analysed before pregnancy (Table I) and during the second trimester. Pregnancy was verified with ultrasound.

CA-125 assay
The CA-125 assays were performed using kits from Centocor Inc. (Malvern, Pennsylvania, USA). For serum samples the one-step IRMA (immunoradiometric assay) was performed and the two-step for PF samples. All assays were performed in duplicates in one run. Intra- and inter-assay coefficients of variation were 3.8 and 5.7% respectively.

The rationale for using two different assays is that early experiments with these kits revealed an artefact when analysing PF samples with a one-step IRMA (Williams et al., 1988Go; Hunter et al., 1990Go). Serially diluted serum samples showed excellent parallelism with the one-step assay but when repeated in PF, a marked ‘hook-effect’ (limited parallelism to the calibration standard) was observed. However, with the two-step IRMA, the parallelism for diluted PF samples was equal to the parallelism observed in serum using the one-step IRMA. The two-step assay involves incubation of a 100 µl sample with capture-MAb (monoclonal antibody) at room temperature, followed by 3 h of incubation with signal-MAb for quantifying CA-125 in PF. Kruitwagen et al. (1991b)Go has recommended using the two-step IRMA for PF samples whereas the one-step is sufficient for serum samples.

Statistical analysis
Statistical analysis was done using linear regression, Kruskal–Wallis, analysis of variance and Mann–Whitney tests where appropriate and a value of P < 0.05 was considered to be statistically significant.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Part 1
CA-125 was detectable in serum from 7/10 (70%) animals (two with spontaneous endometriosis and five controls). The control animals (n = 5) had a mean cycle length of 31 ± 4 days and all had a similar length of follicular phase, luteal phase and menstrual phase (details not shown). The two baboons with spontaneous endometriosis had a mean cycle length of 27 days. In both groups, the concentration of CA-125 in serum was highest during menstruation, with a significant (P < 0.0001, linear regression) decline throughout the menstrual cycle (Figure 1).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Serial serum CA-125 levels during the menstrual cycle were detectable in five out of six baboons with a normal pelvis (a) and two out of four baboons with spontaneous endometriosis (b). Linear regression analysis showed that the highest levels of serum CA-125 were observed during menstruation and that these levels declined progressively and significantly during follicular and luteal phase (P < 0.0001).

 

Part 2
In the serum samples from 12 baboons (28%; eight controls, three with spontaneous endometriosis and one animal with induced endometriosis) CA-125 was not detectable and these samples were excluded for further statistical analysis. No significant changes were observed in CA-125 concentration in serum during different stages of the menstrual cycle in baboons with a normal pelvis, spontaneous or induced endometriosis (Table II).


View this table:
[in this window]
[in a new window]
 
Table II. CA-125 (IU/ml) in peritoneal fluid and serum according to the cycle phase (means ± SD) in controls and in baboons with endometriosis

 

In contrast to the serum samples, CA-125 was detected in all PF samples. In PF from baboons with a normal pelvis, the mean concentration of CA-125 in PF was significantly higher during the follicular phase than during the menstrual or luteal phase (Table II). However, no significant cycle changes were observed in CA-125 levels in PF from baboons with (spontaneous or induced) endometriosis. During both the menstrual and luteal phase, the mean concentration of CA-125 in PF was significantly higher in baboons with (spontaneous or induced) endometriosis than in primates with a normal pelvis (Table II).

The concentration of CA-125 in serum was not affected by lymphocyte suppression, pregnancy or induction of endometriosis. The concentration of PF CA-125 was significantly increased after induction of endometriosis, but lymphocyte suppression and pregnancy had no effect (Table III).


View this table:
[in this window]
[in a new window]
 
Table III. Effects of induction of endometriosis (part 3a), lymphocyte suppression (part 3b) and pregnancy (part 3c) on the concentration of CA-125 (mean ± SD) in serum and peritoneal fluid (PF)

 


    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Serum markers have gained much attention the past 10–15 years in the development of non-invasive diagnostic tools for endometriosis. Several alternatives, such as ultrasonography and magnetic resonance imaging, have failed to detect peritoneal endometriosis (Mais et al., 1993Go; Takahashi et al., 1996Go; Guerriero et al., 1998Go). However, new non-invasive tests are under development, as it has been recently demonstrated that serum IL-6 and PF tumour necrosis factor (TNF)-{alpha} could be used to discriminate between patients with and without endometriosis (Bedaiwy et al., 2002Go).

CA-125 is the most extensively studied serum marker, with high specificity but, unfortunately, low sensitivity. However, some recent studies indicate that CA-125 could be used as an adjuvant together with other markers or methods. In a recent meta-analysis, it was suggested that routine use of CA-125 in subfertile patients could be justified to identify a subgroup likely to benefit from laparoscopy (Mol et al., 1998Go). Other authors have reported that a screening method combining CA-125 with the level of a leukocyte subpopulation increases the positive predictive value in detecting endometriosis (Gagne et al., 2003Go).

In part 1 of the study, a serial analysis of serum CA-125 levels during the menstrual cycle revealed that the highest CA-125 levels were observed during menstruation with subsequent progressive decline during follicular phase and luteal phase, as has also been demonstrated in humans and in rhesus monkeys (Pittaway et al., 1986Go; Lanzone et al., 1991Go; Pittaway and Fayez, 1987Go; Fedele et al., 1988Go; Hornstein et al., 1992Go). These cycle-dependent changes of the CA-125 levels in serum indicate that the CA-125 originates mainly from the endometrium and that the endometrial breakdown is probably associated with direct secretion of CA-125 into the peripheral blood. This idea is shared by several authors (Jäger et al., 1988Go; Zeimet et al., 1993Go; Hompes et al., 1996Go) and supported by the detection of CA-125 in cultured endometrium (Bischof et al., 1986Go) and positive indirect immunoperoxidase staining for CA-125 in endometrial biopsies (Fedele et al., 1989Go).

The purpose of the cross-sectional part of the study was to enable comparisons of serum CA-125 between groups (endometriosis versus controls), since the number of animals was insufficient in the first part for these statistical analyses. Furthermore, the cross-sectional part allowed analyses of changes in PF CA-125 during the cycle. From a methodological point of view, a longitudinal study with serial samples of these changes is superior to the cross-sectional with only one sample/animal/cycle stage. However, this would require daily laparoscopies, introducing the bias of repeated surgery on PF content (inflammatory response to surgery) and CA-125 levels (D’Hooghe et al., 1999Go).

It is not surprising that the significant cycle-dependent changes of CA-125 seen in part 1 (longitudinal study) were not confirmed in part 2 (cross-sectional study), since there were important methodological differences between these two parts. In part 1, a longitudinal design (analysis of serial blood samples from the same baboon during one menstrual cycle) was applied and more samples (n = 264) with detectable serum CA-125 were available. Such longitudinal design is less influenced by inter-individual variability than the cross-sectional method used in part 2, where only one sample per baboon was analysed and the lower number of samples (n = 58) was much lower.

The origin of peritoneal fluid CA-125 is a puzzling question. Our results are consistent with studies in women reporting a poor correlation between the concentration of CA-125 in PF and serum (Ismail et al., 1994Go). Several authors have suggested that non-endometrial sources of PF CA-125 are important, including peritoneum and endometriotic lesions (Fedele et al., 1988Go; Kruitwagen et al., 1991aGo; Ismail et al., 1994Go). Indeed, Barbieri et al. (1986)Go demonstrated the presence of CA-125 on the cell surface of ovarian endometrioma from three patients, whereas other investigators have failed to reproduce these results (Fedele et al., 1988Go, 1989Go). In our study, the induction of endometriosis resulted in a significantly increased concentration of CA-125 in PF (Table III). These results are in line with previous observations in baboons showing an increase in inflammation markers, i.e. leukocytes, macrophages and inflammatory cytokines in PF after induction of endometriosis (D’Hooghe et al., 2001Go). Furthermore, a rise in the concentration of CA-125 in PF has also been demonstrated after abdominal surgery in men (Duk et al., 1986Go). Taken together, these data suggest that both damaged peritoneum and ectopic endometrium are important sources of CA-125 in PF.

In baboons with a normal pelvis (controls), a significantly higher concentration of CA-125 in PF was observed during the follicular phase when compared to menstrual or luteal phase. We hypothesize that it takes a few days before the inflammatory effects of retrograde menstruation in baboons (D’Hooghe et al., 2001Go) result in peritoneal damage leading to increased PF CA-125 concentration during the follicular phase rather than during the menstrual phase. A similar but non-significant trend was observed in PF from baboons with spontaneous endometriosis, probably since the CA-125 levels in PF were significantly higher during menstrual and luteal phase in baboons with spontaneous endometriosis than in those with a normal pelvis (Table II), resulting in the loss of cyclical variation in PF CA-125 concentrations, as has been suggested before in women (Kruitwagen et al., 1991aGo).

Although we reported that the progression of spontaneous endometriosis appears to be faster in immunosuppressed baboons than in controls (D’Hooghe et al., 1995aGo), our hypothesis that lymphocyte suppression increases serum CA-125 levels and PF CA-125 levels in baboons with endometriosis was not confirmed in the current study. This can be explained by the small number of baboons tested, the heterogeneity in terms of presence of endometriosis and cycle stage, and possibly a limited biological effect of general lymphocyte suppression with methylprednisolone and azathioprin on the CA-125 production by endometrium, endometriosis or peritoneum. In spite of these inconclusive results, modulation of the immune system and the inflammatory system are interesting fields of future research. Recently, blocking of the pro-inflammatory cytokine TNF-{alpha} has been demonstrated to reduce the extent of endometriosis in baboons (Barrier et al., 2004Go). Several other cytokines and immunomodulators, such as interleukin-8 and pentoxifylline, could be interesting targets in the development of new drugs against endometriosis.

Although it is generally believed that pregnancy reduces the extent and activity of endometriotic lesions in women, this was not clinically confirmed in baboons (D’Hooghe et al., 1997). Therefore, it is not surprising that we could not confirm the hypothesis that pregnancy reduces serum CA-125 and PF CA-125 levels in baboons with or without endometriosis. This is a relevant observation, since no paired comparisons between CA-125 levels before and during pregnancy are available in women with or without endometriosis. In women, serum CA-125 levels show wide fluctuations during the first trimester with values above normal (Spitzer et al., 1998Go; Bon et al., 2001Go).

The cause of undetectable serum CA-125 in ~30% of the baboons is unclear. PF concentrations are generally 10-fold higher, which is the likely reason why CA-125 was detected in all PF samples as opposed to serum samples. The serum CA-125 concentrations in baboons seem to be lower than serum CA-125 concentrations observed in women, and we speculate that the sensitivity of the human CA-125 kits might have been too low to detect very low values in serum from baboons. This may be related to the speculation by some authors that the molecular structure in PF CA-125 differs from that in serum (Kruitwagen et al., 1991aGo). Finally, inter-species differences between humans and baboons in CA-125 turnover and structure could be additional sources for undetectable values.

In conclusion, serum CA-125 levels were increased during menstruation in all baboons whereas PF CA-125 levels were increased during the follicular phase in baboons with a normal pelvis when compared to other phases of the cycle. Higher PF CA-125 levels were also observed after induction of endometriosis. Finally, PF CA-125 levels were higher in baboons with spontaneous endometriosis when compared to baboons with a normal pelvis during the menstrual and luteal phase. Collectively, these suggest that serum CA-125 originates mainly from bleeding eutopic endometrium whereas CA-125 production in PF seems to come from ectopic endometrium and/or peritoneal damage or inflammation, possibly in response to and following retrograde menstruation The baboon seems to be a valid model for further studies evaluating cause–effect relationships between endometriosis and the production of CA-125 in serum and peritoneal fluid.


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Bambra C (1993) Veterinary Management and Research Techniques for Reproductive Studies in the Baboon: A Practical Approach. Institute of Primate Research, Nairobi.

Barbieri RL, Niloff JM, Bast RC Jr, Scaetzl E, Kistner RW and Knapp RC (1986) Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 45,630–634.[ISI][Medline]

Barrier BF, Bates GW, Leland MM, Leach DA, Robinson RD and Propst AM (2004) Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil Steril, 81(Suppl 1), 775–779.

Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L et al (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. New Engl J Med 13,309,883–887.

Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR and Agarwal A (2002) Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17,426–431.[Abstract/Free Full Text]

Bischof P, Tseng L, Brioschi PA and Herrmann WL (1986) Cancer antigen 125 is produced by human endometrial stromal cells. Hum Reprod 1,423–426.[Abstract]

Bon GG, Kenemans P, Verstraeten AA, Go S, Philipi PA, van Kamp GJ, van Geijn HP and van Vugt JM (2001) Maternal serum CA-125 and Ca15-3 antigen levels in normal and pathological pregnancy. Fetal Diagn Ther 16,166–172.[CrossRef][ISI][Medline]

D’Hooghe TM and Debrock S (2002) Endometriosis, retrograde menstruation and peritoneal inflammation in women and in baboons. Hum Reprod Update 8,84–88.[Abstract/Free Full Text]

D’Hooghe TM, Bambra CS, Cornillie FJ, Isahakia M and Koninckx PR (1991) Prevalence and laparoscopic appearance of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus) Biol Reprod 45,411–416.[Abstract/Free Full Text]

D’Hooghe TM, Bambra CS, Isahakia M and Koninckx PR (1992) Evolution of spontaneous endometriosis in the baboon (Papio anubis, Papio cynocephalus) over a 12-month period. Fertil Steril 58,409–412.[ISI][Medline]

D’Hooghe TM, Bambra CS, Raeymaekers BM, De Jonge I, Lauweryns JM and Koninckx PR (1995a) Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis) Am J Obstet Gynecol, 173, 125–134.[CrossRef][ISI][Medline]

D’Hooghe TM, Bambra CS, Raeymaekers BM, De Jonge I, Hill JA and Koninckx PR (1995b) The effects of lymphocyte suppression on development and progression of endometriosis in baboons (Papio anubis) Fertil Steril 64,172–178.[ISI][Medline]

D’Hooghe TM, Bambra CS, Raeymaekers BM and Koninckx PR (1996a) Serial laparoscopies over 30 months show that endometriosis in captive baboons (Papio anubis, Papio cynocephalus) is a progressive disease. Fertil Steril 65,645–649.[ISI][Medline]

D’Hooghe TM, Bambra CS, Raeymaekers BM, Riday AM, Suleman MA and Koninckx PR (1996b) The cycle pregnancy rate is normal in baboons with stage I endometriosis but decreased in primates with stage II and stage III–IV disease. Fertil Steril 66,809–813.[ISI][Medline]

D’Hooghe TM, Bambra CS, De Jonge I, Lauweryns JM, Raeymaekers BM and Koninckx PR (1997) The effect of pregnancy on endometriosis in baboons (Papio anubis, Papio cynocephalus) Arch Gynecol Obstet 261,15–19.[CrossRef][ISI][Medline]

D’Hooghe TM, Bambra CS, Raeymaekers BM and Hill JA (1999) Pelvic inflammation induced by diagnostic laparoscopy in baboons. Fertil Steril 72,1134–1141.[CrossRef][ISI][Medline]

D’Hooghe TM, Bambra CS, Xiao L, Peixe K and Hill JA (2001) Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus) Am J Obstet Gynecol 184,917–925.[CrossRef][ISI][Medline]

Duk JM, Aalders JG, Fleuren GJ and de Bruijn HW (1986) CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 155,1097–1102.[ISI][Medline]

Fedele L, Vercellini P, Arcaini L, da Dalt MG and Candiani GB (1988) CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis. Am J Obstet Gynecol 158,166–170.[ISI][Medline]

Fedele L, Arcaini L, Baglioni A, Bianchi S and Menard S (1989) What is the source of elevated serum levels of CA 125 in patients with endometriosis? Eur J Obstet Gynecol Reprod Biol 33,247–252.[CrossRef][ISI][Medline]

Gagne D, Rivard M, Page M, Lepine M, Platon C, Shazand K, Hugo P and Gosselin D (2003) Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 levels. Fertil Steril 80,876–885.[CrossRef][ISI][Medline]

Guerriero S, Ajossa S, Mais V, Risalvato A, Lai MP and Melis GB (1998) The diagnosis of endometriomas using colour Doppler energy imaging. Hum Reprod 13,1691–1695.[Abstract]

Hendrickx AG (1971) Reproduction: methods. In Hendrickx AG (ed) Embryology of the Baboon. University of Chicago Press, Chicago, pp 1–44.

Hompes PG, Koninckx PR, Kennedy S, van Kamp GF, Verstraeten RA and Cornillie F (1996) Serum CA-125 concentrations during midfollicular phase, a clinically useful and reproducible marker in diagnosis of advanced endometriosis. Clin Chem 42,1871–1874[Free Full Text]

Hornstein MD, Thomas PP, Gleason RE and Barbieri RL (1992) Menstrual cyclicity of CA-125 in patients with endometriosis. Fertil Steril 58,279–283.[ISI][Medline]

Hunter VJ, Weinberg JB, Haney AF, Soper JT, Lavin P, Metsch L, Knapp RC and Bast RC Jr (1990) CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer. Gynecol Oncol 36,161–165.[CrossRef][ISI][Medline]

Ismail MA, Rotmensch J, Mercer LJ, Block BS, Salti GI and Holt JA (1994) CA-125 in peritoneal fluid from patients with nonmalignant gynaecologic disorders. J Reprod Med 39,510–512.[ISI][Medline]

Jäger W, Meier C, Wildt L, Sauerbrei W and Lang N (1988) CA-125 serum concentrations during the menstrual cycle. Fertil Steril 50,223–227.[ISI][Medline]

Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC and Colvin RB (1983) Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol 2,275–285.[ISI][Medline]

Kruitwagen RF, Thomas C, Poels LG, Koster AM, Willemsen WN and Rolland R (1991a) High CA-125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demonstrated with two-step immunoradiometric assay. Fertil Steril 56,863–869.[ISI][Medline]

Kruitwagen RF, van den Berg RJ, Segers MF, Poels LG, Willemsen WN, Rolland R and Thomas CM (1991b) Quantification of CA 125 in peritoneal fluid: inhibition of the CA 125 response in the one-step immunoradiometric assay and establishment of a two-step assay format. Clin Chem 37,760–761.[Free Full Text]

Lanzone A, Marana R, Muscatello R, Fulghesu AM, Dell’Acqua S, Caruso A and Mancuso S (1991) Serum CA-125 levels in the diagnosis and management of endometriosis. J Reprod Med 36,603–607.[ISI][Medline]

Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM and Melis GB (1993) The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril 60,776–780.[ISI][Medline]

Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F and Bossuyt PM (1998) The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 70,1101–1108.[CrossRef][ISI][Medline]

Patton PE, Field CS, Harms RW and Coulam CB (1986) CA-125 levels in endometriosis. Fertil Steril 45,770–773.[ISI][Medline]

Pittaway DE (1990) The use of serial CA 125 concentrations to monitor endometriosis in infertile women. Am J Obstet Gynecol 163,1032–1035; discussion 1035–1037.[ISI][Medline]

Pittaway DE and Douglas JW (1989) Serum CA-125 in women with endometriosis and chronic pelvic pain. Fertil Steril 51,68–70.[ISI][Medline]

Pittaway DE and Fayez JA (1986) The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril 46,790–795.[ISI][Medline]

Pittaway DE and Fayez JA (1987) Serum CA-125 antigen levels increase during menses. Am J Obstet Gynecol 156,75–76.[ISI][Medline]

Pittaway DE, Klimek M and Koritnik DR (1986) CA-125 antigen in rhesus monkeys with spontaneous endometriosis. Fertil Steril 46,967–969.[ISI][Medline]

Spitzer M, Kaushal N and Benjamin F (1998) Maternal CA-125 levels in pregnancy and the puerperium. J Reprod Med 43,387–392.[ISI][Medline]

Takahashi K, Okada M, Okada S, Kitao M, Imaoka I and Sugimura K (1996) Studies on the detection of small endometrial implants by magnetic resonance imaging using a fat saturation technique. Gynecol Obstet Invest 41,203–206.[ISI][Medline]

Williams RS, Rao CV and Yussman MA (1988) Interference in the measurement of CA-125 in peritoneal fluid. Fertil Steril 1988 49,547–550.[ISI][Medline]

Zeimet AG, Muller-Holzner E, Marth C, Daxenbichler G and Dapunt O (1993) Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil Steril 59,1028–1035.[ISI][Medline]

Submitted on December 22, 2005; resubmitted on May 3, 2005; accepted on May 11, 2005.





This Article
Abstract
Full Text (PDF )
All Versions of this Article:
20/11/3033    most recent
dei181v1
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Request Permissions
Google Scholar
Articles by Falconer, H.
Articles by D’Hooghe, T.M.
PubMed
PubMed Citation
Articles by Falconer, H.
Articles by D’Hooghe, T.M.